Stockreport

Zogenix Announces FDA Extension of Review Period for FINTEPLA® in Dravet Syndrome

Zogenix, Inc.  (ZGNX) 
Last zogenix, inc. earnings: 3/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: zogenixinc.gcs-web.com/investor-overview
PDF EMERYVILLE, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced [Read more]